The Genetics Policy Institute (GPI) and Mary Ann Liebert, Inc., publishers have announced that the 2013 World Stem Cell Report will be published as a special supplement to the peer-reviewed journal Stem Cells and Development. Dr. Graham Parker and Bernard Siegel will serve as Co-Editors-in-Chief, joined by Rosario Isasi (McGill University) as Managing Editor.
It was also announced that Mary Ann Liebert, Inc., publishers and Genetic Engineering & Biotechnology News (GEN), a Liebert publication, will become joint platinum media sponsors of the GPI’s 2013 World Stem Cell Summit that will take place at the Manchester Grand Hyatt San Diego, December 4–6 in San Diego, CA.
Bernard Siegel, Executive Director of GPI and Founder and Co-chair of the Summit said, “We are proud to partner with Graham Parker and the skilled editorial team at Stem Cells and Development to publish our annual Report. The Journal’s extensive audience, combined with the reach of the community attending and supporting the World Stem Cell Summit, will allow our readership to expand exponentially. We will continue to provide an array of specialized articles offering unique insights of leading policy-makers, regulators, and experts in law, ethics, advocacy, industry, and philanthropy from countries, regions, and states. The Report fills a critical unmet need by providing a global framework for all stakeholders.”
Mary Ann Liebert, publisher & CEO of both Stem Cells and Development and GEN stated, “We are delighted to be working with a key thought leader and senior statesman for the field, Bernie Siegel, and his GPI team on this important collaboration. The World Stem Cell Report delivers an orbital and unique viewpoint, with content that is timely, comprehensive, and direct. We are proud to add this important annual publication to our many journals that intersect the world of regenerative medicine.”
GEN Editor-in-Chief John Sterling stated, “The World Stem Cell Summit is the critical global meeting, providing the best opportunity for the GEN community to participate in the world of regenerative medicine. Our platinum media sponsorship allows GEN readers, both in print and online, and advertisers to have a front row seat to listen and learn from the top experts on the very dynamic and expertly conceptualized Summit platform.”
The Report will be made available to all subscribers of Stem Cells and Development and complimentary to attendees of the World Stem Cell Summit. The Summit program delivers on the “big picture” featuring 170+ prominent scientists, business leaders, regulators, policy-makers, advocates, economic development officers, experts in law and ethics, and visionary gurus who will discuss the latest scientific discoveries, business models, legal and regulatory solutions, and best practices. The Summit is expected to attract attendees from more than 40 nations.
About Mary Ann Liebert, Inc., publishers
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
About Stem Cells and Development
Stem Cells and Development is an authoritative peer-reviewed journal dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. Complete tables of content and a free sample issue may be viewed on the Stem Cells and Development website.
About Genetic Engineering & Biotechnology News (GEN)
Genetic Engineering & Biotechnology News, published 21 times a year by Mary Ann Liebert, Inc., publishers, is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine.
About Genetics Policy Institute (GPI) and the World Stem Cell Summit
The Genetics Policy Institute is a nonprofit organization recognized as a leading promoter and defender of stem cell research and other cutting-edge medical research targeting cures. The World Stem Cell Summit is the world’s largest interdisciplinary stem cell meeting and is organized in 2013 by GPI, California Institute for Regenerative Medicine (CIRM), Mayo Clinic, Kyoto University ICEMS, The Scripps Research Institute, and Sanford-Burnham Medical Research Institute.